Michael Shaw

Dr. Michael Shaw

orcid

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 July 2018 in Nanoscale
Verified
Journal Article
Open access
PDF file
ALAndrea Longatti
Andrea Longatti
CSChristina Schindler
Christina Schindler
ACAndie Collinson
Andie Collinson
LJLesley Jenkinson
Lesley Jenkinson
CMCarl Matthews
Carl Matthews
NTNatalie Tigue
Natalie Tigue
Exosomes are extracellular vesicles that mediate cell-to-cell communication by transferring biological cargo, such as DNA, RNA and proteins. Through genetic engineering of exosome-producing cells or manipulation of purified exosomes, it is possible to load exosomes with therapeutic molecules and target them to specific cells via the display of targeting moieties on their surface. This provides an opportunity to exploit a naturally-occurring biological process for therapeutic purposes. In this study, we explored the potential of single chain variable fragments (scFv) as targeting domains to achieve delivery of exosomes to cells expressing a cognate antigen. We generated exosomes targeting the Her2 receptor and, by varying the affinity of the scFvs and the Her2 expression level on recipient cells, we determined that both a high-affinity anti-Her2-scFv (KD ≤ 1 nM) and cells expressing a high level (≥106 copies per cell) of Her2 were optimally required to enable selective uptake. We also demonstrate that targeting exosomes to cells via a specific cell surface receptor can alter their intracellular trafficking route, providing opportunities to influence the efficiency of delivery and fate of intracellular cargo. These experiments provide solid data to support the wider application of exosomes displaying antibody fragments as vehicles for the targeted delivery of therapeutic molecules.

10 July 2014 in Biomedical Optics Express
Verified
Journal Article
Open access
PDF file
KOKevin O’holleran
Kevin O’holleran
MSMichael Shaw
Michael Shaw
The use of structured illumination in fluorescence microscopy allows the suppression of out of focus light and an increase in effective spatial resolution. In this paper we consider different approaches for reconstructing 2D structured illumination images in order to combine these two attributes, to allow fast, optically sectioned, superresolution imaging. We present a linear reconstruction method that maximizes the axial frequency extent of the combined 2D structured illumination passband along with an empirically optimized approximation to this scheme. These reconstruction methods are compared to other schemes using structured illumination images of fluorescent samples. For sinusoidal excitation at half the incoherent cutoff frequency we find that removing information in the zero order passband except for a small region close to the excitation frequency, where it replaces the complementary information from the displaced first order passband, enables optimal reconstruction of optically sectioned images with enhanced spatial resolution.

1 April 2016 in Journal of Thrombosis and Haemostasis
Verified
Journal Article
Open access
PDF file
DWDavid Westmoreland
David Westmoreland
MSMichael Shaw
Michael Shaw
WGWilliam Grimes
William Grimes
DMDaniel J. Metcalf
Daniel J. Metcalf
JBJemima Burden
Jemima Burden
DCDaniel F. Cutler
Daniel F. Cutler
Many platelet functions are dependent on bioactive molecules released from their granules. Deficiencies of these granules in number, shape or content are associated with bleeding. The small size of these granules is such that imaging them for diagnosis has traditionally required electron microscopy. However, recently developed super-resolution microscopes provide sufficient spatial resolution to effectively image platelet granules. When combined with automated image analysis, these methods provide a quantitative, unbiased, rapidly acquired dataset that can readily and reliably reveal differences in platelet granules between individuals. To demonstrate the ability of structured illumination microscopy (SIM) to efficiently differentiate between healthy volunteers and three patients with Hermansky-Pudlak syndrome. Blood samples were taken from three patients with Hermansky-Pudlak syndrome and seven controls. Patients 1-3 have gene defects in HPS1, HPS6 and HPS5, respectively; all controls were healthy volunteers. Platelet-rich plasma was isolated from blood and the platelets fixed, stained for CD63 and processed for analysis by immunofluorescence microscopy, using a custom-built SIM microscope. SIM can successfully resolve CD63-positive structures in fixed platelets. A determination of the number of CD63-positive structures per platelet allowed us to conclude that each patient was significantly different from all of the controls with 99% confidence. A super-resolution imaging approach is effective and rapid in objectively differentiating between patients with a platelet bleeding disorder and healthy volunteers. CD63 is a useful marker for predicting Hermansky-Pudlak syndrome and could be used in the diagnosis of patients suspected of other platelet granule disorders.

3 December 2019 in ACS Nano
Verified
Journal Article
Open access
IKIbolya Kepiro
Ibolya Kepiro
IMIrene Marzuoli
Irene Marzuoli
KHKatharine Hammond
Katharine Hammond
Xiaoliang BaXiaoliang Ba
Xiaoliang Ba
HLHelen Lewis
Helen Lewis
MRMaxim Ryadnov
Maxim Ryadnov
Antimicrobial resistance stimulates the search for antimicrobial forms that may be less subject to acquired resistance. Here we report a conceptual design of protein pseudo-capsids exhibiting a broad spectrum of antimicrobial activities. Unlike conventional antibiotics, these agents are effective against phenotypic bacterial variants, while clearing “superbugs” in vivo without toxicity. The design adopts an icosahedral architecture that is polymorphic in size, but not in shape, and that is available in both L and D epimeric forms. Using a combination of nanoscale and single-cell imaging we demonstrate that such pseudo-capsids inflict rapid and irreparable damage to bacterial cells. In phospholipid membranes they rapidly convert into nanopores, which remain confined to the binding positions of individual pseudo-capsids. This mechanism ensures precisely delivered influxes of high antimicrobial doses, rendering the design a versatile platform for engineering structurally diverse and functionally persistent antimicrobial agents.

1 October 2015 in Methods
Verified
Journal Article
Closed access
MSMichael Shaw
Michael Shaw
LZLydia Zajiczek
Lydia Zajiczek
KOKevin O’holleran
Kevin O’holleran

1 January 2017 in Nanomedicine: Nanotechnology, Biology and Medicine
Verified
Journal Article
Closed access
CEClara L. Essmann
Clara L. Essmann
MEMuna Elmi
Muna Elmi
MSMichael Shaw
Michael Shaw
GAGiridhar M. Anand
Giridhar M. Anand
VPVijay M. Pawar
Vijay M. Pawar
MSMandayam A. Srinivasan
Mandayam A. Srinivasan